PKS Holdings Limited, a healthcare technology company, engages in the development and provision of software services for the healthcare industry in Australia, Europe, the Americas, and internationally. More Details
+ 1 more risk
Flawless balance sheet with high growth potential.
Share Price & News
How has PKS Holdings's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: PKS's share price has been volatile over the past 3 months.
7 Day Return
AU Healthcare Services
1 Year Return
AU Healthcare Services
Return vs Industry: PKS exceeded the Australian Healthcare Services industry which returned 4.3% over the past year.
Return vs Market: PKS exceeded the Australian Market which returned -6.9% over the past year.
Price Volatility Vs. Market
How volatile is PKS Holdings's share price compared to the market and industry in the last 5 years?
Simply Wall St News
6 days ago | Simply Wall StA Look At The Fair Value Of PKS Holdings Limited (ASX:PKS)
1 month ago | Simply Wall StWe're Interested To See How PKS Holdings (ASX:PKS) Uses Its Cash Hoard To Grow
5 months ago | Simply Wall StCould PKS Holdings Limited's (ASX:PKS) Investor Composition Influence The Stock Price?
Is PKS Holdings undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: PKS (A$0.31) is trading below our estimate of fair value (A$0.35)
Significantly Below Fair Value: PKS is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: PKS is poor value based on its PE Ratio (101.7x) compared to the XX Healthcare Services industry average (57.8x).
PE vs Market: PKS is poor value based on its PE Ratio (101.7x) compared to the Australian market (21.5x).
Price to Earnings Growth Ratio
PEG Ratio: PKS is poor value based on its PEG Ratio (2.2x)
Price to Book Ratio
PB vs Industry: PKS is good value based on its PB Ratio (2x) compared to the AU Healthcare Services industry average (5.6x).
How is PKS Holdings forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PKS's forecast earnings growth (46.9% per year) is above the savings rate (2.3%).
Earnings vs Market: PKS's earnings (46.9% per year) are forecast to grow faster than the Australian market (17.7% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: PKS's revenue (33.3% per year) is forecast to grow faster than the Australian market (4.6% per year).
High Growth Revenue: PKS's revenue (33.3% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: PKS's Return on Equity is forecast to be low in 3 years time (12%).
How has PKS Holdings performed over the past 5 years?
Last years revenue growth
Earnings and Revenue History
Quality Earnings: PKS has a large one-off gain of A$135.9K impacting its June 30 2020 financial results.
Growing Profit Margin: PKS became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if PKS's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: PKS has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: PKS has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare Services industry (-10.5%).
Return on Equity
High ROE: PKS's Return on Equity (1.3%) is considered low.
How is PKS Holdings's financial position?
Financial Position Analysis
Short Term Liabilities: PKS's short term assets (A$5.5M) exceed its short term liabilities (A$2.8M).
Long Term Liabilities: PKS's short term assets (A$5.5M) exceed its long term liabilities (A$218.7K).
Debt to Equity History and Analysis
Debt Level: PKS is debt free.
Reducing Debt: PKS has not had any debt for past 5 years.
Debt Coverage: PKS has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: PKS has no debt, therefore coverage of interest payments is not a concern.
What is PKS Holdings's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate PKS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate PKS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if PKS's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if PKS's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of PKS's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Mr. Tim Kelsey has been Commercial Director at Telstra Health since July 1, 2016. Mr. Kelsey serves as the Chief Executive Officer at PKS Holdings Limited since October 2020. Mr. Kelsey served as the Chief ...
|Independent Non-Executive Director||1.42yrs||AU$104.65k||0.72% |
|Non-Executive Director||1.42yrs||AU$365.37k||0.13% |
|Non-Executive Director||1yr||AU$45.45k||0.53% |
|Independent Non-Executive Chairman||1.42yrs||AU$80.00k||0.73% |
|Independent Non-Executive Director||1.42yrs||AU$68.93k||0.13% |
|Non-Executive Director||0.33yr||AU$5.00k||5.31% |
Experienced Board: PKS's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: PKS insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 54.7%.
PKS Holdings Limited's company bio, employee growth, exchange listings and data sources
- Name: PKS Holdings Limited
- Ticker: PKS
- Exchange: ASX
- Founded: 1996
- Industry: Health Care Technology
- Sector: Healthcare
- Market Cap: AU$58.085m
- Shares outstanding: 187.37m
- Website: https://www.pks.com.au
Number of Employees
- PKS Holdings Limited
- 50 Holt Street
- 3rd floor
- Surry Hills
- New South Wales
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|PKS||ASX (Australian Securities Exchange)||Yes||Ordinary Shares||AU||AUD||Jun 2019|
|PKS||CHIA (Chi-X Australia)||Yes||Ordinary Shares||AU||AUD||Jun 2019|
PKS Holdings Limited, a healthcare technology company, engages in the development and provision of software services for the healthcare industry in Australia, Europe, the Americas, and internationally. It ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/10/25 10:35|
|End of Day Share Price||2020/10/23 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.